Rock Springs Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Rock Springs Capital Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-247,200	Closed	-$8.36M	–	167
2021 Q2	$8.36M	Buy	247,200 +15,200	+7%	+$387K	0.17%	123
2021 Q1	$5.43M	Sell	232,000 -743	-0.3%	-$22.5K	0.12%	129
2020 Q4	$6.7M	Sell	232,743 -282,937	-55%	-$7.12M	0.14%	131
2020 Q3	$10.4M	Hold	515,680	–	–	0.27%	100
2020 Q2	$15.5M	Buy	515,680 +282,180	+121%	+$10.2M	0.43%	78
2020 Q1	$7.34M	Hold	233,500	–	–	0.3%	86
2019 Q4	$11M	Buy	+233,500	New	+$6.74M	0.35%	82

Rock Springs Capital Management's CNST Position: Q3 2021 in Review

Rock Springs Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 247,200 shares — an estimated $8.36M sold.

Rock Springs Capital Management first reported a position in CNST in Q4 2019 and held it in 7 quarters. The position peaked at $15.5M in Q2 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Rock Springs Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Rock Springs Capital Management sold 247,200 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $8.36M.
Rock Springs Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 7 quarters.
Rock Springs Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $15.5M in Q2 2020.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Rock Springs Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.